"Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics (PVDOMICS)". Pulmonary Vascular Disease (PVD) is a poorly understood but lethal condition. Currently, pulmonary hypertension (PH) is nosologically divided into Groups associated with primary vascular abnormalities, left-sided heart failure, pulmonary parenchymal and thromboembolic diseases. It is likely that these different forms of PH share common mechanistic pathways leading to PVD that might be targeted therapeutically, but currently these ostensible shared mechanisms remain poorly understood. In order to better understand the fundamental mechanisms of PVD in PH, this application seeks to enroll large numbers of people with each form of PH and perform detailed phenotyping of clinical, hemodynamic, functional, biomarker, metabolomic, and proteomic patterns.

Public Health Relevance

Pulmonary hypertension (PH) is a poorly understood and deadly condition that can be caused by numerous processes. Treatment options for the majority of patients with PH are limited, and in this research, we seek to rigorously characterize different forms of PH to help develop new treatment strategies.

Agency
National Institute of Health (NIH)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01HL125205-01
Application #
8795892
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Xiao, Lei
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905